Κυριακή 9 Ιουλίου 2017

Histaminergic Angioedema.

Related Articles

Histaminergic Angioedema.

Immunol Allergy Clin North Am. 2017 Aug;37(3):467-481

Authors: Busse PJ, Smith T

Abstract
Angioedema is frequently categorized into histamine- or bradykinin-mediated disease. It is critical to determine the underlying mediator of symptoms as it directs treatment. Histaminergic angioedema is the most frequent cause of angioedema. It is classified as either acute (lasting <6 weeks) or chronic (symptoms >6 weeks). It is further classified into angioedema presenting with or without urticaria. Some patients with acute angioedema may have disease that becomes chronic. Mast cells and basophils are central to the underlying pathophysiology of histamine-mediated angioedema. The underlying treatments of histamine-mediated angioedema are antihistamines, corticosteroids, and epinephrine.

PMID: 28687103 [PubMed - in process]



from #ENT-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2u1sGzl

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.